AQIA (Aquiva Group) Interest Coverage: N/A (As of Sep. 2008)


What is Aquiva Group Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Aquiva Group's Operating Income for the three months ended in Sep. 2008 was $-2.32 Mil. Aquiva Group's Interest Expense for the three months ended in Sep. 2008 was $0.00 Mil. GuruFocus does not calculate 's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for Aquiva Group's Interest Coverage or its related term are showing as below:


AQIA's Interest Coverage is not ranked *
in the Software industry.
Industry Median: 24.78
* Ranked among companies with meaningful Interest Coverage only.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Aquiva Group  (OTCPK:AQIA) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .

Aquiva Group Interest Coverage Related Terms

Aquiva Group Interest Coverage Historical Data

* Premium members only.

The historical data trend for Aquiva Group's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

Aquiva Group Interest Coverage Chart

Aquiva Group Annual Data
Trend Mar06 Mar07 Mar08
Interest Coverage
No Debt No Debt N/A

Aquiva Group Quarterly Data
Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08
Interest Coverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only No Debt No Debt N/A N/A N/A

AQIA vs LOGQ, MUSS, KLMN: Interest Coverage Comparison

For the Software - Application subindustry, Aquiva Group's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aquiva Group Interest Coverage vs Software Industry

For the Software industry and Technology sector, Aquiva Group's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Aquiva Group's Interest Coverage falls into.


Aquiva Group Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Aquiva Group's Interest Coverage for the fiscal year that ended in Mar. 2008 is calculated as

Here, for the fiscal year that ended in Mar. 2008, Aquiva Group's Interest Expense was $0.00 Mil. Its Operating Income was $-0.14 Mil. And its Long-Term Debt & Capital Lease Obligation was $0.50 Mil.

GuruFocus does not calculate Aquiva Group's interest coverage with the available data.

Aquiva Group's Interest Coverage for the quarter that ended in Sep. 2008 is calculated as

Here, for the three months ended in Sep. 2008, Aquiva Group's Interest Expense was $0.00 Mil. Its Operating Income was $-2.32 Mil. And its Long-Term Debt & Capital Lease Obligation was $1.75 Mil.

GuruFocus does not calculate Aquiva Group's interest coverage with the available data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.

Aquiva Group Business Description

Address No. 3 Bethesda Metro Center, Suite 700, Bethesda, MD, USA, 20814
Aquiva Group Inc is focused on commercializing materials science technologies in both existing and emerging markets. It has licensed a novel HiPNATM (Hydrogel with InterPenetrating Network Anchor) technology, branded as AquiFormTM, which is a versatile material with key properties, making it an attractive platform for various applications. These applications include transdermal patches that release active ingredients for skin care, nutraceuticals, and other healthcare and cosmetics markets. The company operates across three segments: Consumer Health, Wellness, & Cosmetics; Medical Device; and Therapeutics & Transdermal Drug-Delivery Systems (TDS). Additionally, it is building on an established partnership network and capabilities in contract development to expand its services to new areas.